VAPB and amyotrophic lateral sclerosis: Moreover, TDP-43 was shown to disrupt the VAPB-PTPIP52 pathway (Stoica et al., 2016), suggesting a similar mechanism in idiopathic ALS cases with pathogenic TDP-43 accumulation.